7-methoxytacrine has been researched along with dizocilpine maleate in 1 studies
| Studies (7-methoxytacrine) | Trials (7-methoxytacrine) | Recent Studies (post-2010) (7-methoxytacrine) | Studies (dizocilpine maleate) | Trials (dizocilpine maleate) | Recent Studies (post-2010) (dizocilpine maleate) |
|---|---|---|---|---|---|
| 52 | 1 | 28 | 7,741 | 9 | 1,449 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holubova, K; Horak, M; Kaniakova, M; Kleteckova, L; Korabecny, J; Korinek, M; Krusek, J; Lichnerova, K; Skrenkova, K; Smejkalova, T; Soukup, O; Vales, K | 1 |
1 other study(ies) available for 7-methoxytacrine and dizocilpine maleate
| Article | Year |
|---|---|
7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
Topics: Animals; Cells, Cultured; Dizocilpine Maleate; Dose-Response Relationship, Drug; Hippocampus; Humans; Locomotion; Male; Memantine; Mutation; Neurons; Neuroprotective Agents; Prepulse Inhibition; Rats; Receptors, N-Methyl-D-Aspartate; Tacrine | 2018 |